The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

Oral decongestants containing phenylephrine were found not to be effective. However, nasal sprays of the same drug are not subject to the FDA’s proposed order.

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

The IV solution supply chain is still recovering after Hurricane Helene damaged a manufacturing site in North Carolina. 

The pharmacy chain is accused of charging insurance more for generic drugs than uninsured customers of its Prescription Saving Club.

A program dubbed the Clean Power Prescription sends half the energy generated by 519 solar panels on the hospital's roof back to patients, in the form of energy credits. 

With generative AI coming into its own, AI regulators must avoid relying too much on principles of risk management—and not enough on those of uncertainty management.